AltruBio to Present at Biotech Showcase™ 2022
Top Life Sciences Startups to Watch in 2022
Life Science Leader─What Trends Are 9 Biopharma CEOs Paying Attention To?
Podcast─CMC Developability Assessments For Rapid Ph.1 Entry With AltruBio's Gene Lee, Ph.D.
AltruBio to Present Abstract on Checkpoint Regulator Neihulizumab as a Novel Therapy for Immunological Diseases at the B&T Cell-Mediated Autoimmune Disease Drug Development Virtual Summit
BioPharm International─Trends in Outsourcing of Bioprocess Development